10.1002/cssc.201701707
ChemSusChem
FULL PAPER
coated with a fluorescent indicator; detection was carried out using UV light
(λ = 254 and 365 nm) and permanganate or molybdophosphoric acid
solutions followed by heating. Flash column chromatography was
performed using Merck Kieselgel 60 (300-400 mesh) as the stationary
phase. 1H-NMR spectra were recorded at 300 or 400 MHz, 13C-NMR
spectra were recorded at 75.5 or 100.6 MHz, respectively, and 31P-NMR
spectra were recorded at 121 MHz. Chemical shifts were referenced to the
residual solvent peak (CDCl3, δ 7.26 ppm for 1H-NMR, δ 77.16 ppm for
13C-NMR; THF-d8, δ 1.72 and 3.58 ppm for 1H-NMR, δ 25.31 and 67.21
ppm for 13C-NMR). FT-IR spectra were recorded in the range 4000-400
cm–1 with a 2 cm–1 resolution. ESI-MS spectra were obtained by direct
injection of the sample and are reported in the form m/z (intensity relative
to base = 100).
aqueous phase was washed with fresh ethyl acetate (3 10 mL), then the
combined organic phases were washed with brine (20 mL) and dried with
Na2SO4. After filtration and removal of the solvent under vacuum, the
reaction crude was purified by flash column chromatography (SiO2,
petroleum ether/AcOEt 30:1). Desired product 6 (83 mg, 0.15 mmol, 76%
yield) was isolated as a dense yellow oil. 1H–NMR (300 MHz, CDCl3): δ =
7.30–7.37 (m, 2H), 7.21–7.30 (m, 4H), 7.07–7.15 (m, 5H), 6.98–7.06 (m,
4H), 6.73 (d, J = 16.2 Hz, 1H), 6.28 (s, 1H), 3.92 (s, 2H), 3.86 (s, 2H),
1.26–1.39 (m, 16H), 0.91 (t, J = 7.0 Hz, 6H) ppm. 13C–NMR (75 MHz,
CDCl3): δ = 150.1, 147.7, 147.1, 146.7, 131.8, 129.4, 127.2, 125.6, 124.5,
123.8, 123.1, 122.0, 117.4, 101.8, 77.9, 77.7, 43.9, 32.8 (2), 32.0 (2),
22.7 (2), 22.6 (2), 14.2 (2) ppm. IR (KBr): 휈̃ = 3026, 2927, 1591, 1483,
1375, 1277, 1030 cm–1. ESI–MS: m/z = 565 [M]+.
(3,3-dipentyl-3,4-dihydro-2H-thieno[3,4-b][1,4]dioxepin-6-
(E)-8-(4-(diphenylamino)styryl)-3,3-dipentyl-3,4-dihydro-2H-
yl)methanol (2). 3,3-dipentyl-3,4-dihydro-2H-thieno[3,4-b][1,4]dioxepine-
6-carbaldehyde (1, 1.02 g, 3.15 mmol, 1.0 eq) was dissolved in CH2Cl2 (15
mL) and methanol (20 mL), then, after cooling to 0 °C, sodium borohydride
(0.202 g, 5.34 mmol, 1.7 eq.) was added into the reaction vessel. The
resulting mixture was stirred at 0 °C for 30 minutes, then at room
temperature for other 30 minutes. A saturated aqueous solution of NH4Cl
(45 mL) was added into the flask and the mixture was stirred until hydrogen
production ceased, then the two phases were separated. The aqueous
phase was extracted with CH2Cl2 (2 15 mL), then the combined organic
phases were washed with brine and dried with Na2SO4. After filtration,
removal of the solvent afforded alcohol 2 (1.01 g, 3.09 mmol, 98% yield)
as an orange oil which was used for the next step without further
purification. 1H–NMR (300 MHz, CDCl3): δ = 6.36 (s, 1H), 4.61 (s, 2H),
3.84 (s, 2H), 3.82 (s, 2H), 2.41 (bs, 1H), 1.26–1.34 (m, 16H), 0.89 (t, J =
7.0 Hz, 6H) ppm. 13C–NMR (75 MHz, CDCl3): δ = 149.5, 146.8, 121.2,
thieno[3,4-b][1,4]dioxepine-6-carbaldehyde (7). Compound 6 (0.85 g,
1.53 mmol, 1.0 eq.) was dissolved in THF (15 mL), then, after cooling to –
78 °C, n-BuLi (1.6 M solution in pentane, 1.40 mL, 2.25 mmol, 1.5 eq) was
added in the reaction vessel. After one hour under stirring at – 78 °C, N,N-
DMF (0.22 g, 3.00 mmol, 0.23 mL, 2.0 eq.) was added, then the reaction
mixture was slowly warmed to room temperature and stirred for 16 h. After
this time, a saturated aqueous solution of NH4Cl (12 mL) was added, then
THF was evaporated under vacuum and the aqueous phase was extracted
with ethyl acetate (3 30 mL). The combined organic phases were washed
with brine (2 70 mL) and dried with Na2SO4. After filtration and removal
of the solvent under vacuum, a dense orange oil corresponding to a 10:1
mixture of aldehyde 7 and an unidentified side product (0.84 g, 90% approx.
yield of aldehyde 7) was obtained and used as such for the following
reaction. Characterization data for aldehyde 7: 1H–NMR (300 MHz,
CDCl3): δ = 9.88 (s, 1H), 6.95–7.37 (m, 16H), 4.07 (s, 2H), 3.98 (s, 2H),
1.25–1.42 (m, 16H), 0.91 (t, J = 6.8 Hz, 6H) ppm. 13C–NMR (75 MHz,
CDCl3): δ = 180.6, 156.7, 148.3, 147.4, 145.8, 132.8, 130.7, 130.1, 129.5,
128.0, 125.0, 123.6, 123.0, 118.2, 116.0, 78.2, 78.0, 43.9, 32.7 (×2), 32.2
103.2, 77.2, 76.7, 56.7, 43.9, 32.7, 31.8, 22.6, 22.5, 14.1 ppm. IR (KBr): 휈
̃
= 3410, 3112, 2930, 2861, 1459, 1412, 1376, 1206, 1164, 1016 cm–1. ESI–
MS: m/z = 349 [M+Na]+, 309 [M–OH]+.
(×2), 22.7 (×4), 14.2 (×2) ppm. IR (KBr): 휈̃ = 2924, 1642, 1589, 1485, 1424,
1278, 1049 cm–1. ESI–MS: m/z = 608 [M+Me]+ (peak derived from the
formation of the emiacetal of aldehyde 7 with MeOH).
Diethyl
((3,3-dipentyl-3,4-dihydro-2H-thieno[3,4-b][1,4]dioxepin-6-
yl)methyl)phosphonate (4). Alcohol 2 (1.39 g, 4.25 mmol, 1.0 eq.) was
dissolved in THF (30 mL), then the solution was cooled to –5 °C and PBr3
(1.17 g, 4.33 mmol, 0.41 mL, 3.0 eq.) was added into the reaction vessel.
The resulting dark mixture was stirred at 0 °C for 30 minutes, then triethyl
phosphite (2.12 g, 12.8 mmol, 2.17 mL, 3.0 eq.) was added dropwise at
room temperature. The resulting mixture was stirred at reflux for 7 h and
then at 60 °C for 10 h. After cooling to room temperature, the solvent was
removed under vacuum. Purification by flash column chromatography
(SiO2, petroleum ether/AcOEt from 3:1 to 1:1) afforded desired product 4
(1.56 g, 3.49 mmol, 82% yield) as a yellow oil. 1H–NMR (300 MHz, CDCl3):
δ = 6.31 (d, J = 2.7 Hz, 1H), 4.03–4.13 (m, 4H), 3.82 (s, 2H), 3.80 (s, 2H),
3.20 (d, J = 20.3, 2H), 1.33–1.25 (m, 22H), 0.88 (t, J = 7.0 Hz, 6H) ppm.
13C–NMR (75 MHz, CDCl3): δ = 149.3 (d, J = 3.6 Hz), 147.4 (d, J = 9.7 Hz),
111.5 (d, J = 11.3 Hz), 102.5 (d, J = 4.2 Hz), 77.9, 77.8, 62.4 (d, J = 6.5
Hz), 44.0, 32.8 (2), 31.7 (2), 24.6 (d, J = 144.3 Hz), 22.7 (2), 22.6 (2),
16.5 (d, J = 6.0 Hz), 14.2 (2) ppm. 31P–NMR (121 MHz, CDCl3): δ = 24.5
(E)-2-cyano-3-(8-((E)-4-(diphenylamino)styryl)-3,3-dipentyl-3,4-
dihydro-2H-thieno[3,4-b][1,4]dioxepin-6-yl)acrylic
acid
(MB25).
Aldehyde 7 (0.48 g, 0.82 mmol, 1.0 eq.), as obtained in the previous step,
was dissolved in toluene (45 mL), then cyanoacetic acid (0.69 g, 8.15
mmol, 10 eq.), ammonium acetate (0.25 g, 3.28 mmol, 4.0 eq.) and acetic
acid (65 mL) were added to the reaction vessel. The reaction mixture was
heated under stirring at 120° C for 4 h, then cooled to room temperature
and diluted with AcOEt (200 mL). The organic phase was washed with aq.
NH4Cl 1M (230 mL + 4 70 mL) and brine (150 mL), then dried with
Na2SO4. After filtration and removal of the solvent under vacuum, the
reaction crude was purified by flash column chromatography (SiO2, CH2Cl2,
then CH2Cl2/AcOH 98:2). Desired product MB25 (0.35 g, 0.53 mmol, 65%
yield) was isolated as dark red solid. 1H–NMR (300 MHz, CDCl3): δ = 8.41
(s, 1H), 7.33–7.40 (m, 2H), 7.24–7.32 (m, 4H), 7.04–7.16 (m, 8H), 6.97–
7.04 (m, 2H), 4.10 (s, 2H), 3.98 (s, 2H), 1.31–1.39 (m, 16H), 0.91 (t, J =
6.9 Hz, 6H) ppm. 13C–NMR (75 MHz, CDCl3): δ = 169.1, 156.8, 148.7,
147.2, 145.7, 143.5, 135.3, 132.5, 129.7, 129.5, 128.3, 125.2, 123.8, 122.5,
116.8, 115.3, 113.2, 91.5, 78.3, 77.4, 43.7, 32.7 (×2), 32.2 (×2), 22.7 (×4),
(s) ppm. IR (KBr): 휈̃ = 3112, 2930, 1724, 1648, 1497, 1377, 1258, 1029
cm–1. ESI–MS: m/z = 915 [2M+Na]+, 447 [M+H]+.
(E)-4-(2-(3,3-dipentyl-3,4-dihydro-2H-thieno[3,4-b][1,4]dioxepin-6-
yl)vinyl)-N,N-diphenylaniline (6). 4-(diphenylamino)-benzaldehyde (5,
53 mg, 0.19 mmol, 1.0 eq.) was dissolved in THF (0.3 mL), then a solution
of phosphonate 4 (100 mg, 0.22 mmol, 1.2 eq.) in THF (1.0 mL) was added
to the reaction vessel. After cooling to 0 °C, NaHMDS (70 mg, 0.38 mmol,
2.0 eq.) was added. The reaction mixture was stirred at 0 °C for 15 minutes,
then at room temperature for other 15 minutes and, finally, at reflux
temperature for 16 h. After cooling to room temperature, water (4 mL) was
added and the resulting mixture was concentrated under vacuum. After
dilution with ethyl acetate (5 mL), the two phases were separated. The
14.2 (×2) ppm. IR (KBr): 휈̃ = 3423, 2930, 2857, 2213, 1681, 1564, 1480,
1242, 1049 cm–1. ESI-MS: m/z = 661 [M+1]+.
8-(5-(4-(diphenylamino)phenyl)thiophen-2-yl)-3,3-dipentyl-3,4-
dihydro-2H-thieno[3,4-b][1,4]dioxepine-6-carbaldehyde (11). 3,3-
dipentyl-3,4-dihydro-2H-thieno[3,4-b][1,4]dioxepine-6-carbaldehyde
(1,
0.35 g, 1.08 mmol, 1.0 eq) was dissolved in chloroform (8 mL) and acetic
acid (4 mL), then N-bromosuccinimide (0.21 g, 1.19 mmol, 1.1 eq.) was
added to the reaction vessel. The reaction mixture was stirred at room
This article is protected by copyright. All rights reserved.